Lawrence Dean Flanders, M.D
NPI 1811382120ActiveIndividual· Ophthalmology, Cornea and External Diseases Specialist· Chevy Chase, MD
Ophthalmology, Cornea and External Diseases Specialist (M.D) in Chevy Chase, Maryland, trained at Ohio State University College of Medicine (class of 2015). Their prescriptions cost Medicare Part D more than their services did: $633,251 for 946 claims, against $308,719 paid for services in 2024. Tarsus Pharmaceuticals, Inc. was the largest of 4 companies reporting payments in 2025, $119.96 in all, mostly food and beverage.
Overview
| NPI | 1811382120 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D |
| Sole proprietor | Yes |
| NPI issued | Apr 2, 2015 |
| Last updated in NPPES | Aug 13, 2020 |
| Certified by provider | Aug 13, 2020 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Ophthalmology, Cornea and External Diseases Specialist Primary | 207WX0120X | D0090134 | MD |
| Ophthalmology | 207W00000X | A161279 | CA |
| Ophthalmology | 207W00000X | D0090134 | MD |
| Ophthalmology | 207W00000X | MD048660 | DC |
| Ophthalmology, Cornea and External Diseases Specialist | 207WX0120X | MD048660 | DC |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Ophthalmology (DC) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 868 |
|---|---|
| Services billed | 3,330 across 46 procedure codes |
| Paid by Medicare | $308,719 |
Part D prescriptions in 2024
| Prescriptions (claims) | 946 · 1,429 30-day fills |
|---|---|
| Patients | 243 |
| Total drug cost | $633,251 |
| Generic share | 55% of claims |
Education and affiliations
| Medical school | Ohio State University College of Medicine |
|---|---|
| Graduation year | 2015 |
| Medicare specialty | Ophthalmology |
Medical group
- Washington Eye Physicians and Surgeons PCChevy Chase, MD · 9 clinicians
Industry payments (Open Payments)
- 2025$119.96 · 5 payments from 4 companies
- 2024$136.34 · 5 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $39.85 | 1 |
| Biotissue Holdings Inc. | $29.67 | 2 |
| Rxsight Inc | $27.69 | 1 |
| Dompe US, Inc. | $22.75 | 1 |
What the 2025 payments were for
- Food and Beverage$119.96 · 5 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records